Trial intelligence / Profile preview

Paracervical Block During Intracavitary Brachytherapy for Cervical Cancer

jRCT1061250070Recruiting

Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine in Cervical Cancer (CC) (2 arms). Primary endpoint: Primary: NRS at Tandem insertion (T2). Started Dec 2025; status: recruiting.

02

Drugs

lidocaine
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on jRCT1061250070.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1061250070.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call